BMC Cancer
Papers 10,000
1 page of 1,000 pages (10k results)
#1Qing Shen (KI: Karolinska Institute)H-Index: 4
#2Maria E. C. Schelin (Lund University)H-Index: 6
Last. Anna Jöud (Lund University)H-Index: 13
view all 4 authors...
Background null The Swedish healthcare is decentralised to 21 regions. Detailed information on all delivered care in the southernmost region, Skane, is prospectively collected in the Skane Healthcare Register (SHR). The data is updated daily and hence a good source for epidemiological studies. However, the diagnostic codes used to identify cancer patients in SHR have not yet been validated. null Methods null We conducted a validation study including 1,473,204 residents in Skane region during 200...
#1Peiyi Xie (Sun Yat-sen University)H-Index: 2
#1Peiyi Xie (Sun Yat-sen University)H-Index: 6
Last. Xiao-chun Meng (Sun Yat-sen University)H-Index: 14
view all 10 authors...
BACKGROUND Atypical tumor response patterns during immune checkpoint inhibitor therapy pose a challenge to clinicians and investigators in immuno-oncology practice. This study evaluated tumor burden dynamics to identify imaging biomarkers for treatment response and overall survival (OS) in advanced gastrointestinal malignancies treated with PD-1/PD-L1 inhibitors. METHODS This retrospective study enrolled a total of 198 target lesions in 75 patients with advanced gastrointestinal malignancies tre...
#1Lucy Wanjiku Macharia (UFRJ: Federal University of Rio de Janeiro)H-Index: 5
#2Wanjiru MuriithiH-Index: 1
Last. Vivaldo Moura-Neto (UFRJ: Federal University of Rio de Janeiro)H-Index: 27
view all 10 authors...
BACKGROUND Glioblastoma is a fatal brain tumour with a poor patient survival outcome. Hypoxia has been shown to reprogram cells towards a stem cell phenotype associated with self-renewal and drug resistance properties. Activation of hypoxia-inducible factors (HIFs) helps in cellular adaptation mechanisms under hypoxia. Similarly, miRNAs are known to be dysregulated in GBM have been shown to act as critical mediators of the hypoxic response and to regulate key processes involved in tumorigenesis....
#1Satoshi Kawakami (University of Yamanashi)H-Index: 4
#2Shinichi Takano (University of Yamanashi)H-Index: 17
Last. Naohiro Hosomura (University of Yamanashi)H-Index: 10
view all 16 authors...
BACKGROUND The genetic changes underlying carcinogenesis in patients with risk factors of gallbladder carcinoma (GBC) remains controversial, especially in patients with pancreaticobiliary maljunction (PBM). This study aimed to clarify the association between risk factors of GBC and genetic changes using next-generation sequencing (NGS). METHODS We retrospectively analyzed resected tissues of 64 patients who were diagnosed with GBC (n = 26), PBM [with GBC (n = 8), without GBC (n = 20)], and chron...
#1Ralf Gutzmer (RUB: Ruhr University Bochum)H-Index: 2
#2Caroline Robert (Institut Gustave Roussy)H-Index: 130
Last. Reinhard Dummer (UZH: University of Zurich)H-Index: 132
view all 8 authors...
BACKGROUND The BOLT study for sonidegib, a Hedgehog pathway inhibitor (HHI) approved for patients with locally advanced basal cell carcinoma (laBCC) not amenable to curative surgery or radiotherapy, used modified Response Evaluation Criteria in Solid Tumors (mRECIST) for laBCC tumor evaluation. The ERIVANCE study for vismodegib, another HHI, used a composite RECIST endpoint of ≥30% reduction in externally visible tumor or radiographic dimension, or complete ulceration resolution. This preplanned...
#1Jung Hyun Jo (Yonsei University)H-Index: 11
#2Kim Sun AH-Index: 9
Last. Si Young Song (Yonsei University)H-Index: 54
view all 10 authors...
BACKGROUND Cancer stem cells (CSCs) are implicated in carcinogenesis, cancer progression, and recurrence. Several biomarkers have been described for pancreatic ductal adenocarcinoma (PDAC) CSCs; however, their function and mechanism remain unclear. METHOD In this study, secretome analysis was performed in pancreatic CSC-enriched spheres and control adherent cells for biomarker discovery. Glutaredoxin3 (GLRX3), a novel candidate upregulated in spheres, was evaluated for its function and clinical ...
#1Florian Gebauer (University of Cologne)H-Index: 22
#2Alexander Ioannis Damanakis (University of Cologne)
Last. Dirk Waldschmidt (University of Cologne)H-Index: 15
view all 11 authors...
According to current guidelines, treatment of patients with hepatic oligometastasis in pancreatic cancer is not reflected and systemic chemotherapy is recommended in those patients. Retrospective data suggest beneficial outcomes in patients with hepatic oligometastasis, though prospective data from clinical trials addressing this particular patient group is not available. In this single arm, phase-2 trial, survival data from patients receiving neoadjuvant chemotherapy followed by R0/R1 resection...
#1Sven Jacob (LMU: Ludwig-Maximilians-Universität München)H-Index: 2
#2Florian Bösch (LMU: Ludwig-Maximilians-Universität München)H-Index: 9
Last. Thomas Kirchner (LMU: Ludwig-Maximilians-Universität München)H-Index: 60
view all 13 authors...
BACKGROUND Molecular differences in colorectal cancer (CRC) are associated with the metastatic route. Patient survival is mainly driven by metastatic spread thus it is imperative to understand its key drivers to develop biomarkers for risk stratification, follow-up protocols and personalized therapy. Thus, this study aimed to identify genes associated with the metastatic route in CRC. MATERIAL AND METHODS CRC patients resected at our clinic from 2005 to 2014 and with a minimum 5-year follow-up w...
#1Laura A. Gray (University of Sheffield)H-Index: 5
#2Mónica Hernández Alava (University of Sheffield)H-Index: 14
Last. Allan Wailoo (University of Sheffield)H-Index: 38
view all 3 authors...
BACKGROUND The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the benefits and costs of treatments across different diseases and treatments using a common metric. QALYs can be calculated using preference-based measures (PBMs) such as EQ-5D-3L, but clinical studies often focus on objective clinician or laboratory measured outcomes and non-preferen...
#1Matthias Balk (FAU: University of Erlangen-Nuremberg)H-Index: 1
#2R Rupp (FAU: University of Erlangen-Nuremberg)H-Index: 2
Last. Sabine Semrau (FAU: University of Erlangen-Nuremberg)H-Index: 20
view all 14 authors...
In contrast to head and neck squamous cell carcinoma (HNSCC), the effect of treatment duration in HNSCC-CUP has not been thoroughly investigated. Thus, this study aimed to assess the impact of the time interval between surgery and adjuvant therapy on the oncologic outcome, in particular the 5-year overall survival rate (OS), in advanced stage, HPV-negative CUPs at a tertiary referral hospital. 5-year disease specific survival rate (DSS) and progression free survival rate (PFS) are defined as sec...
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.